BUSINESS
Glenmark Pharmaceuticals executes agreement to transfer its API business
Glenmark Pharmaceuticals has executed business purchase agreement for transfer of the company’s API business to its wholly owned subsidiary — Glenmark Life…
Glenmark Pharmaceuticals has executed business purchase agreement for transfer of the company’s API business to its wholly owned subsidiary — Glenmark Life…
Glenmark Pharmaceuticals has launched the biosimilar of Adalimumab under a licensing agreement with Cadila Healthcare, the Zydus group for the treatment of…